XML 27 R55.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Business Segments - Segments in Significant Accounting Policies (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Dec. 31, 2019
Jun. 30, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Segment Reporting Information          
Net sales $ 214,012   $ 218,223 $ 403,732 $ 418,376
Depreciation and amortization 8,148   6,841 15,929 13,532
Reconciliation of income before income taxes to Adjusted EBITDA          
Income before income taxes 16,895   20,074 20,467 42,779
Interest expense, net 3,432   3,015 6,786 5,798
Depreciation and amortization 8,148   6,841 15,929 13,532
Stock-based compensation       1,129 1,129
Acquisition-related costs of goods sold       280  
Foreign currency (gains) losses, net (718)   2,617 2,503 (18)
Identifiable assets 788,318 $ 726,671   788,318  
Animal Health          
Segment Reporting Information          
Net sales 143,689   139,562 265,539 270,751
Reconciliation of income before income taxes to Adjusted EBITDA          
Restructure costs   6,281      
Mineral Nutrition          
Segment Reporting Information          
Net sales 55,685   62,319 108,334 117,157
Performance Products          
Segment Reporting Information          
Net sales 14,638   16,342 29,859 30,468
Operating Segments          
Segment Reporting Information          
Net sales 214,012   218,223 403,732 418,376
Depreciation and amortization 7,757   6,388 15,131 12,614
Adjusted EBITDA - Total segments 38,979   41,523 68,367 80,518
Reconciliation of income before income taxes to Adjusted EBITDA          
Income before income taxes 16,895   20,074 20,467 42,779
Interest expense, net 3,432   3,015 6,786 5,798
Depreciation and amortization 7,757   6,388 15,131 12,614
Restructure costs       425  
Stock-based compensation 564   564 1,129 1,129
Acquisition-related costs of goods sold       280  
Acquisition-related transaction costs       462  
Acquisition-related other 167     167  
Other, net     (1,506)   (1,506)
Foreign currency (gains) losses, net (718)   2,617 2,503 (18)
Adjusted EBITDA - Total segments 38,979   41,523 68,367 80,518
Identifiable assets 676,439 609,412   676,439  
Operating Segments | Animal Health          
Segment Reporting Information          
Net sales 143,689   139,562 265,539 270,751
Depreciation and amortization 6,711   5,493 13,095 10,849
Adjusted EBITDA - Total segments 33,838   35,925 58,899 71,641
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 6,711   5,493 13,095 10,849
Adjusted EBITDA - Total segments 33,838   35,925 58,899 71,641
Identifiable assets 572,921 508,864   572,921  
Operating Segments | Mineral Nutrition          
Segment Reporting Information          
Net sales 55,685   62,319 108,334 117,157
Depreciation and amortization 629   616 1,242 1,213
Adjusted EBITDA - Total segments 3,684   4,084 7,159 6,647
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 629   616 1,242 1,213
Adjusted EBITDA - Total segments 3,684   4,084 7,159 6,647
Identifiable assets 69,988 67,662   69,988  
Operating Segments | Performance Products          
Segment Reporting Information          
Net sales 14,638   16,342 29,859 30,468
Depreciation and amortization 417   279 794 552
Adjusted EBITDA - Total segments 1,457   1,514 2,309 2,230
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 417   279 794 552
Adjusted EBITDA - Total segments 1,457   1,514 2,309 2,230
Identifiable assets 33,530 32,886   33,530  
Corporate          
Segment Reporting Information          
Depreciation and amortization 391   453 798 918
Reconciliation of income before income taxes to Adjusted EBITDA          
Depreciation and amortization 391   453 798 918
Corporate costs 10,491   $ 9,918 20,219 $ 18,804
Identifiable assets $ 111,879 $ 117,259   $ 111,879